Entelevest’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$612K Buy
510
+46
+10% +$47K 0.52% 44
2026
Q1
$427K Sell
464
-8
-2% -$8.11K 0.43% 55
2025
Q4
$507K Buy
+472
New +$451K 0.51% 46

Other funds holding LLY

Entelevest's LLY Position: Q2 2026 in Review

Entelevest increased its Eli Lilly (LLY) stake by 9.9% in Q2 2026, buying an estimated $47K and bringing the position to 510 shares worth $612K. The position accounts for 0.52% of the portfolio, ranked #44.

Entelevest first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 1,616 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Entelevest held 510 shares of Eli Lilly worth $612K as of Q2 2026.
  • Entelevest bought 46 Eli Lilly shares in Q2 2026, an estimated $47K.
  • Eli Lilly made up 0.52% of Entelevest's portfolio in Q2 2026, its #44 holding.
  • Entelevest first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 1,616 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Entelevest's 13F filing for Q2 2026, filed 22 Jul 2026.